Compositions and methods for increasing tetrahydrobiopterin plasma exposure
US12257252B2 · kind B2 · utility
0Cited by
24References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2019 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Mar 6, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4985
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma exposure of BH4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.